glp-1 drugs pharmaceutical companies news 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Pipeline Update: August 2025

Acetyl-L-Carnitine Powder is a versatile amino acid supplement that supports energy production and cognitive function

The Unstoppable Rise of GLP-1 Agonists: Revolutionising Diabetes and Obesity Treatment Over the past two years, the pharmaceutical industry has witnessed an unprecedented surge in the development and deployment of GLP-1 receptor agonists

Nov 7, 2024: FDA Proposes Ending Oral Phenylephrine in OTC Cold Medications: The FDA has announced that it is proposing to removed oral phenylephrine as an active ingredient that can be used in OTC drug products for the temporary relief of nasal congestion

BPC-157 + NAD+ BPC-157 accelerates tissue repair by upregulating growth factor signaling (VEGF, EGF), promoting angiogenesis, and modulating nitric oxide pathways

In the CY 2026 OPPS/ASC proposed rule, we stated that we believed that CPT code 97007 most closely describes the primary service currently described by CPT code 0662T, while CPT codes 97008 and 97009 describe ancillary services for which payment would be packaged in the primary service

Surgeons, anesthesiologists, and primary care providers should collaborate to create a unified plan